Woodline Partners »

Vanda Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Vanda Pharmaceuticals (VNDA) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Vanda Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vanda Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vanda Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 208k 6.91

More positions owned by Woodline Partners

NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Johnson & Johnson (JNJ)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Revolution Medicines (RVMD)
Verizon Communications (VZ)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Applied Materials (AMAT)
Texas Instruments Incorporated (TXN)

View all positions for Woodline Partners

Top funds holding Vanda Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
AIGH Capital Management
Vanguard Capital Management
Millennium Management
Acadian Asset Management
Dimensional Fund Advisors
AQR Capital Management
Geode Capital Management
Two Sigma Investments
State Street Corporation
Krensavage Asset Management
Jacobs Levy Equity Management
Vanguard Portfolio Management

View all funds holding Vanda Pharmaceuticals